EIF2AK3 and cancer: In particular, in cancer cells, it has been demonstrated that GRP78 attenuates ROS by activating protein kinase RNA-like endoplasmic reticulum kinase (PERK)-NRF2 signals [65,66], leading to upregulation of antioxidant-related genes as well as enhancing the protein levels of glycolytic enzymes [67].